Menu ×

HEALTHCARE & PHARMACEUTICAL

Oncology Medical Devices Market Segmentation By Product (Brachytherapy Devices and Endoscopic Devices); By End User (Cancer Research Institutes, Hospitals and Others); By Therapeutic (Chemotherapy, Hormone therapy, Biotherapy and Radiation Therapy); By Diagnosis (Biopsy, Imaging, Endoscopy and Blood Tests) – Global Demand Analysis & Opportunity Outlook 2027

  • Text Size:

Global Oncology Medical Devices Market Overview

Oncology is a branch of science that investigates cancer cells. The oncology devices market includes medical devices that help in the diagnosis and treatment of cancer diseases. For successful treatment of cancer, screening and detection are very important at an early stage. Cancer can occur to anybody at any point in life.

Market Size and Forecast

The global oncology medical devices market is anticipated to grow significantly over the forecast period i.e. 2019-2027. The market is segmented by product, application, therapeutic and diagnosis, and end user. By end user, the hospitals segment is anticipated to have significant growth on account of rise in rate of hospitalization for cancer treatment and a wide range of services offered by hospitals under one roof.

On the basis of product, the oncology devices market is divided into brachytherapy devices and endoscopic devices. The endoscopic devices segment is expected to expand at a higher pace owing to growing preferences for these devices among doctors for screening of the infected site, which helps in the early detection of cancer. Based on end user segment, the oncology medical devices market is divided into cancer research institutes hospitals and others. CLICK TO DOWNLOAD FREE SAMPLE

Oncology medical Devices market Graph

Growth Drivers:

Ever-growing number of Patients

The number of patients affected by different types of cancer such as lung, colorectal and breast cancer are increasing day by day due to different reasons.  According to a report published by WHO, 2018, lung cancer is predominant among cancers and caused approximately 1.69 million deaths in 2015. This ever-growing patient population is expected to boost the growth of the oncology medical devices market.

Increase in Consumption of Tobacco Products

In developing countries such as Brazil, China and India, the people who are consuming tobacco products are increasing which is a major cause of lung cancer among the patient population. The increase in consumption of tobacco products is expected to propel the growth of oncology medical devices market.

Help in diagnosis and treatment

The oncology medical devices prove very helpful in diagnosis and treatment of cancer which is expected to boost the growth of the oncology medical devices market.

Restraints

High cost of oncology devices

Since the oncology devices are used to treat and diagnose cancer, it is very important that the device should provide proper information and possess up to date technology so that there should not be any discrepancy at a later stage. To keep the devices up to date and their perfect functioning, high costs are to be born. The high cost of oncology devices is expected to hamper the growth of the oncology medical devices market. 

Stringent approval process

The oncology medical devices are used for the diagnosis and treatment of cancer which is a fatal disease. If there is any discrepancy in the devices that can prove fatal for a patient which means that there is no scope for discrepancy or any short comings in the oncology medical devices. Stringent government rules are projected to hamper the growth of oncology medical devices market in the next few years.

Side effects of the therapy

There can be side effects of the therapy such as local swelling, local bruising, and others which can impede the growth of the oncology medical devices market. 

Market Segmentation

Our-in depth analysis of the global oncology medical devices market includes the following segments:

By Product

  • Brachytherapy devices
  • Endoscopic devices

By End User

  • Cancer Research Institutes
  • Hospitals
  • Others

By Therapeutic

  • Chemotherapy
  • Hormone therapy
  • Biotherapy
  • Radiation therapy

By Diagnosis

  • Biopsy
  • Imaging
  • Endoscopy
  • Blood tests

By Region

On the basis of regional analysis, the global oncology medical devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

North America is expected to hold a major share in the market during the forecast period owing to rise in incidence of cancer in the region. According to the National Cancer Institute, in 2017, almost 1.73 million new cancer cases were diagnosed in the U.S. Moreover, in 2017, an estimated 15,270 children and adolescents under 19 years of age were diagnosed with cancer. Europe is expected to grow at a significant rate on the back of growth in cancer population and availability of favorable reimbursement policies for diagnosis of cancer. Asia Pacific is expected to grow attributing to increase in cancer among the tobacco-consuming population, rise in adoption of advanced devices in the hospitals and as well as well-developed hospital infrastructures. Middle East & Africa are expected to grow owing to rise in disposable income of people, growing incidences of cancer and availability of modern diagnostic procedures coupled with favorable health care infrastructure.

The global oncology medical devices market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Top Featured Companies Dominating the Market

  • Accuray Technologies
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • GE Healthcare
  • Eckert and Ziegler BEBIG
  • IBA Group
  • Biogenex Laboratories
  • Varian Medical Systems
  • C.R Bard Inc.
  • Roche Diagnostics
  • Elekta AB
Factors Covered for Market Penetration
Factors to be Considered for maximum ROI
Connect with our Analyst

Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2019 Research Nester. All Rights Reserved